Currently, Alterity Therapeutics Ltd ADR’s (ATHE) stock is trading at $4.44, marking a gain of 3.02% from last night’s close. At this price, the stock is -36.57% below its 52-week high of $7.00 and 343.56% above its 52-week low of $1.00. Based on the past 30-day period, the stock price is -14.06% below the high and +17.32% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, ATHE’s SMA-200 is $4.10.
How does Alterity Therapeutics Ltd ADR (ATHE) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 3 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.33 in simple terms.
Alterity Therapeutics Ltd ADR (ATHE): Earnings History
If we examine Alterity Therapeutics Ltd ADR’s recent earnings history, in the last quarter ended on Next Year (2027), it posted adjusted earnings per share of -$1.1, beating the consensus of -$0.84. In other words, it topped the consensus by -$1.1, resulting in a -1.1 surprise. In the 3 months period before the previous quarter which was closed on Next Year (2027), the stock recorded adjusted earnings per share of -$1.1 in contrast with the Outlook of -$0.84. That was a difference of -$1.1 and a surprise of -1.1.
Alterity Therapeutics Ltd ADR (NASDAQ: ATHE) Ownership Details
I will give a breakdown of the key shareholders in Alterity Therapeutics Ltd ADR (ATHE). Recent figures show that the company’s insiders hold 0.00% of shares. A total of 14 institutional investors hold shares in the company, making 1.23% of its stock and 1.23% of its float.
Aug 31, 2025, it was reported that the Company’s largest institutional holder is Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holding total of 1.16 shares that make 0.01% of the company’s total number of shares and are currently priced at 5082.0.
An overview of Alterity Therapeutics Ltd ADR’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Alterity Therapeutics Ltd ADR (ATHE) traded 213,561 shares per day, with a moving average of $4.30 and price change of -0.54. With the moving average of $4.80 and a price change of -1.18, about 100,689 shares changed hands on average over the past 50 days. Finally, ATHE’s 100-day average volume is 97,178 shares, alongside a moving average of $4.64 and a price change of +0.30.
